Delynov Chirurgie, Delynov Minimally invasive mitral valve repair: second clamping remains a safe option In minimally invasive mitral valve repair (MI-MVr) surgery, transoesophageal echocardiography monitoring after the initial aortic unclamping often presents a critical clinical dilemma. Facing... Nov 23, 2025
Delynov Chirurgie, Delynov Cardiac Amyloidosis: M-TEER to Treat Iatrogenic Chordal Rupture Transthyretin amyloid cardiomyopathy (ATTR-CA) already imposes a poor prognosis and complex management. However, the diagnostic arsenal itself can become a source of co... Nov 21, 2025
Delynov Chirurgie, Delynov Mitral valve repair: robotics equals conventional surgery for 5-year survival Mitral valve repair (MVr) has become the therapeutic gold standard for degenerative mitral regurgitation (DMR). While the rise of robotics since 1996 has expanded the range of approaches... Nov 20, 2025
Delynov Chirurgie, Delynov Neonatal Hypoxemia: Tricuspid Cleft, a Major Diagnostic Pitfall When faced with immediate neonatal cyanosis, clinicians primarily focus on persistent pulmonary hypertension (PPHN). However, this clinical presentation can mask... Nov 19, 2025
Delynov Chirurgie, Delynov T-TEER: dedicated devices more effective than MitraClip Tricuspid regurgitation (TR) remains a major valvular pathology, often associated with advanced heart failure and a degraded quality of life. Yet, surgery... Nov 17, 2025
Delynov Chirurgie, Delynov Thoracic trauma: thoracotomy or sternotomy to manage hemorrhage? Although fewer than 10% of thoracic traumas require surgical intervention, these cases present extreme morbidity and mortality, reaching 52% in cases of... Nov 17, 2025
Delynov Chirurgie, Delynov TAVR and aortic chordae: how to secure valve implantation? Aortic chordae tendineae (ACT) are rare embryonic fibrous remnants attached between the leaflets and the aortic sinus wall. Although often clinically silent... Nov 14, 2025
Delynov Chirurgie, Delynov TAVR and aortic chordae: how to manage this rare obstacle? Transcatheter aortic valve replacement (TAVR) faces complex anatomical challenges, particularly the presence of aortic chordae tendineae (ACT). These embryonic remnants... Nov 14, 2025
Delynov Chirurgie, Delynov Transapical TAVR: securing the valve against aortic chordae Aortic chordae tendineae (ACT) are rare embryonic fibrous remnants, typically asymptomatic, yet their involvement in specific regurgitations or stenoses remains a clinical consideration. Nov 14, 2025
Delynov Chirurgie, Delynov TAVR: should aortic chordae be feared during implantation? Aortic chordae tendineae (ACT) are rare embryonic fibrous remnants, typically clinically silent. However, the rise of transcatheter aortic valve replacement... Nov 14, 2025
Delynov Chirurgie, Delynov TAVR and aortic chordae: prosthesis remains stable after rupture Aortic chordae tendineae (ACT) are rare fibrous embryonic remnants, usually asymptomatic, yet their impact on valve replacement procedures... Nov 14, 2025
Delynov Chirurgie, Delynov TAVR and aortic chordae: prosthetic stability remains optimal Aortic chordae tendineae (ACT) are rare embryonic remnants, usually asymptomatic, but capable of complicating the management of aortic insufficie... Nov 14, 2025
